[go: up one dir, main page]

WO2019048526A1 - Procédé de préparation de 1-[6-halogéno-3-pyridyl]cétones - Google Patents

Procédé de préparation de 1-[6-halogéno-3-pyridyl]cétones Download PDF

Info

Publication number
WO2019048526A1
WO2019048526A1 PCT/EP2018/073963 EP2018073963W WO2019048526A1 WO 2019048526 A1 WO2019048526 A1 WO 2019048526A1 EP 2018073963 W EP2018073963 W EP 2018073963W WO 2019048526 A1 WO2019048526 A1 WO 2019048526A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
process according
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2018/073963
Other languages
English (en)
Inventor
Christoph SCHOTES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of WO2019048526A1 publication Critical patent/WO2019048526A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the present invention relates to a process for preparing l-[6-halogeno-3-pyridyl]ketones, and optionally further reacting such ketones to triazole derivatives. It further relates to l -[6-halogeno-3-pyridyl]ketones and to 3-bromo-6-chloro-2-(trifluoromethyl)pyridine. l-[6-halogeno-3-pyridyl]ketones are known to be valuable intermediates in the synthesis of compounds useful in the field of crop protection. WO 2017/029179 Al discloses respective triazole compounds and several routes to synthesize those.
  • process B comprises synthesis of l -[6-halogeno-3-pyridyl]ketones which are converted in several steps to triazole derivatives.
  • l -[6-halogeno-3-pyridyl]ketones are formed by converting dihalogenated pyridine derivatives into Grignard compounds and subsequently reacting such Grignard compounds with acyl chlorides to the desired ketones.
  • the acylation step is performed in the presence of a catalyst, in particular a catalyst selected from copper chloride, aluminum chloride or lithium chloride.
  • object of the invention is provision of an improved process for the synthesis of l-[6-halogeno-3- pyridyl]ketones.
  • l -[6-halogeno-3-pyridyl]ketones can be synthesized in high yield and without the need of adding any catalyst by converting dihalogenated pyridine derivatives into Grignard reagents and further reacting those with acyl anhydrides.
  • subject of this invention is a process for preparing a compound of formula (I)
  • R represents hydrogen, Ci-C 2 -halogenalkyl, Ci-C 2 -halogenalkoxy, Ci-C 2 -alkylcarbonyl, fluorine chlorine;
  • R 1 represents Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C/t- alkyl, phenyl, phenyl-Ci-C4-alkyl, phenyl-C 2 -C4-alkenyl or phenyl-C 2 -C4-alkynyl; and - -
  • X represents fluorine or chlorine; characterized in that a compound of formula (II)
  • R and X are defined as in formula (I); is reacted in a first step A) with a compound of formula (III)
  • R represents Ci-C6-alkyl or Cs-Cs-cycloalkyl
  • Y represents chlorine or bromine
  • R 1 is defined as in formula (I).
  • step A) the compound of formula (II) is reacted with a Grignard reagent.
  • the Grignard reagent is represented by formula (III).
  • Grignard compounds undergo a solvent-dependent equilibrium between different magnesium compounds that can be described by the so-called Schlenck equilibrium.
  • the Schlenck equilibrium for the Grignard reagent according to formula (III) can be schematically illustrated as follows:
  • formula (III) encompasses not only the structures as depicted, but also the structures resulting from the Schleck equilibrium as well as the respective solvent adducts.
  • Formula (I) provides a general definition of the ketones obtainable by the process according to the invention.
  • Preferred radical definitions for fonnula (I) shown above and below are given below. These definitions apply to the end products of formula (I) and likewise to all educts and intermediates bearing the respective radical(s).
  • R preferably represents Ci-C2-halogenalkyl or G-C2-halogenalkoxy. R more preferably represents Ci-halogenalkyl.
  • R more preferably represents CF 3 , CHF 2 , CH 2 F, OCF 3 , OCHF 2 or OCH 2 F.
  • R most preferably represents CF3.
  • R 1 preferably represents G-C4-alkyl, C 2 -Ce-alkenyl, C 2 -C6-alkynyl, cyclopropyl, phenyl, benzyl, phenylethenyl or phenylethinyl.
  • R 1 more preferably represents methyl, ethyl, propyl, isopropyl, butyl, cyclopropyl, CF 3 , allyl, CH 2 C ⁇ C-CH 3 or CH 2 C ⁇ CH.
  • R 1 more preferably represents methyl, ethyl, propyl, isopropyl, butyl or cyclopropyl.
  • R 1 more preferably represents methyl or ethyl.
  • R 1 most preferably represents methyl
  • X most preferably represents chlorine.
  • R' preferably represents G-C 4 -alkyl or C 2 -C6-cycloalkyl.
  • R' more preferably represents methyl, ethyl, propyl, isopropyl, butyl or cyclopropyl.
  • R' more preferably represents methyl, ethyl, propyl, isopropyl or butyl.
  • R' most preferably represents isopropyl.
  • Y most preferably represents chlorine.
  • radical definitions and explanations given above in general terms or stated within preferred ranges can, however, also be combined with one another as desired, i.e. including between the particular ranges and preferred ranges. They apply both to the end products and correspondingly to precursors and intermediates. In addition, individual definitions may not apply.
  • R represents Ci-C6-alkyl or C3-Cs-cycloalkyl, preferably isopropyl
  • Y represents chlorine or bromine, preferably chlorine; and the resulting product is reacted in step B) with the anhydride of formula (IVa)
  • present invention refers to a process, wherein a compound of formula (I) is synthesized as outlined above and is further reacted to a triazole derivative of formula (VI)
  • R and R 1 are defined as in formula (I);
  • R 4 represents halogen, CN, nitro, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, Ci-C 4 -alkylcarbonyl, hydroxy-substituted Ci-C 4 -alkyl or pentafluoro- 6 -sulfanyl; and m is an integer and is 0, 1, 2, 3, 4 or 5; characterized in that the reaction of the compound of formula (I) to the triazole derivative of formula (VI) comprises the following steps : step C): reacting the compound of formula (I) with a phenol derivative of formula (VII)
  • R 4 and m are defined as in formula (VI); in the presence of a base to a compound of formula (VIII) - -
  • R 4 preferably represents halogen, CN, nitro, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, C1-C4- halogenalkoxy or pentafluoro- 6 -sulfanyl.
  • R 4 more preferably represents CF3, OCF3, Br, CI or pentafluoro- 6 -sulfanyl.
  • R 4 more preferably represents CF 3 , OCF 3 , Br, CI or pentafluoro- 6 -sulfanyl in the 4-position of the phenyl moiety.
  • R 4 most preferably represents Br or CI, preferably in the 4-position of the phenyl moiety, m preferably is 1. 2 or 3. m more preferably is 1 or 2. m most preferably is 1.
  • R is defined as in formula (I); with hydrogen chloride in the presence of dinitrogen trioxide or an organic nitrite.
  • gaseous hydrogen chloride is used. This means the hydrogen chloride is added in gaseous state and remains in the gaseous state under the specific reaction conditions.
  • the reaction is preferably conducted at a temperature of from 0 to 30 °C and a pressure of from 0.5 to 2 bar.
  • this reaction is carried out in the presence of an solvent, preferably selected from dichloromethane, trichloromethane, tetrachloromethane, 1 ,2-dichloroethane, 1,1, 1 -trichloroethane, 1 , 1 ,2-trichloroethane, cyclohexane, methylcyclohexane, heptane, hexane, trifluoromethylbenzene, 4- chloro-trifluoromethylbenzene, chlorobenzene, 1 ,2-dichlorobenzene, 1,3-dichlorobenzene, acetic acid, trifluoroacetic acid, nitrobenzene, tetrahydrofuran, methyltetrahydrofuran, in particular 2- methyltetrahydrofuran, dioxane, acetonitrile, diethylether, cyclopropyl methyl ether, ieri-butyl methyl ether
  • the organic nitrite is preferably selected from methyl nitrite, ethyl nitrite, isopropyl nitrite, isobutyl nitrite and teri-butyl nitrite. Preferred is teri-butyl nitrite.
  • Ci-C6-alkyl comprises the largest range defined here for an alkyl radical. Specifically, this definition comprises the meanings methyl, ethyl, n-, isopropyl, n-, iso-, sec-, tert-butyl, and also in each case all isomeric pentyls and hexyls, such as methyl, ethyl, propyl, 1 -methylethyl, butyl, 1 -methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2- dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1 -ethylpropyl, n-hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,2-dimethyl
  • Ci-C4-alkyl such as methyl, ethyl, n-, isopropyl, n-, iso-, sec-, tert-butyl.
  • the definition Ci-C 2 -alkyl comprises methyl and ethyl.
  • the definition halogen comprises fluorine, chlorine, bromine and iodine.
  • Halogen-substituted alkyl - e.g. referred to as halogenalkyl, halogenoalkyl or haloalkyl, e.g. C1-C4- halogenalkyl or Ci-C 2 -halogenalkyl - represents, for example, Ci-C4-alkyl or Ci-C 2 -alkyl as defined above substituted by one or more halogen substituents which can be the same or different.
  • C1-C4- halogenalkyl represents chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-fluoroethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2- dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, 1,1-difluoroethyl, pentafluoroethyl, 1-fluoro-l -methylethyl, 2- fluoro- 1 , 1 -dimethylethyl, 2-fluoro- 1 -fluoromethyl- 1 -methylethyl, 2-fluoro-
  • Ci-C 2 -halogenalkyl represents chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2- fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, 1,1-difluoroethyl, pentafluoroethyl.
  • Ci-C4-alkyl represents, for example, Ci-C4-alkyl as defined above substituted by one or more fluorine substituent(s).
  • Preferably mono- or multiple fluorinated Ci-C4-alkyl represents fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 1-fluoro-l -methylethyl, 2-fluoro- 1,1 -dimethylethyl, 2-fluoro- 1- fluoromethyl- 1 -methylethyl, 2-fluoro- l,l-di(fluoromethyl)-ethyl, l-methyl-3-trifluoromethylbutyl, 3- methyl- 1 -trifluoromethylbutyl.
  • C 2 -C6-alkenyl comprises the largest range defined here for an alkenyl radical. Specifically, this definition comprises the meanings ethenyl, n-, isopropenyl, n-, iso-, sec-, tert-butenyl, and also in each case all isomeric pentenyls, hexenyls, 1 -methyl- 1-propenyl, 1 -ethyl- 1 -butenyl. Halogen-substituted alkenyl - -
  • C2-C6-haloalkenyl - represents, for example, C2-C6-alkenyl as defined above substituted by one or more halogen substituents which can be the same or different.
  • C2-C6-alkynyl comprises the largest range defined here for an alkynyl radical. Specifically, this definition comprises the meanings ethynyl, n-, isopropynyl, n-, iso-, sec-, tert-butynyl, and also in each case all isomeric pentynyls, hexynyls.
  • Halogen-substituted alkynyl - referred to as C2-C6-haloalkynyl - represents, for example, C2-C6-alkynyl as defined above substituted by one or more halogen substituents which can be the same or different.
  • Cs-Cs-cycloalkyl comprises monocyclic saturated hydrocarbyl groups having 3 to 8 carbon ring members, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
  • Grignard compounds may be formed, which are represented by formula (II-Gr) and/or (II-Br)
  • R, X and Y are defined as outlined above.
  • Grignard compounds generally undergo a solvent-dependent equilibrium between different magnesium compounds that can be described by the so-called Schlenck equilibrium.
  • Schlenck equilibrium the so-called Schlenck equilibrium.
  • step A) may work-up for example in order to isolate, concentrate, dilute or purify the Grignard compound or a solution or suspension thereof.
  • step B) it is preferred to conduct step A) and step B) without any treatment like isolation or purification of the reaction product resulting from step A). It is particularly preferred to add the reaction mixture resulting from step A) to the anhydride of formula (IV).
  • step A) and step B) are carried out in the presence of an aprotic solvent, preferably selected from tetrahydrofuran, methyltetrahydrofuran, in particular 2-methyltetrahydrofuran, diethylether, cyclopropyl methyl ether, teri-butyl methyl ether, toluene and mixtures thereof, more preferably from tetrahydrofuran, toluene and mixtures thereof.
  • an aprotic solvent preferably selected from tetrahydrofuran, methyltetrahydrofuran, in particular 2-methyltetrahydrofuran, diethylether, cyclopropyl methyl ether, teri-butyl methyl ether, toluene and mixtures thereof, more preferably from tetrahydrofuran, toluene and mixtures thereof.
  • step A) and step B) are carried out at a temperature of -30°C to 50°C, preferably -10°C to
  • the compound of formula (II) and the compound of formula (III) are reacted in a molar ratio of 1 : 0.8 to 1 : 1.5, more preferred 1 : 0.9 to 1 : 1.4, more preferred about 1 : 1 to 1 : 1.3, most preferred 1 : 1 to 1 : 1.1.
  • the Grignard reagent of formula (III) is preferably used as solution in an aprotic solvent, in particular as solution in tetrahydrofuran, particularly preferred as a 1.0 to 3.0 molar solution in tetrahydrofuran.
  • the Grignard reagent of formula (III) is added as solution in an aprotic solvent, preferably tetrahydrofuran, to a reaction vessel or flask containing the compound of formula (II) and an aprotic solvent, preferably toluene.
  • an aprotic solvent preferably tetrahydrofuran
  • the molar ratio of compound of formula (II) and anhydride of formula (TV) is 1 : 1 to 1 : 2, more preferred 1 : 1.05 to 1 : 1.8, more preferred 1 : 1.1 to 1 : 1.5, most preferred 1 : 1.1 to 1 : 1.3.
  • step A) and step B) are carried out under anhydrous conditions, preferably under argon atmosphere.
  • step B) is conducted in the absence of a copper catalyst, more preferred in the absence of any catalyst. Even more preferred also in step A) no catalyst is present.
  • the reaction mixture resulting from step B) can be worked-up by procedures generally known in the art.
  • the reaction mixture is quenched by addition of water and/or saturated aqueous ammonium chloride solution, the resulting organic and aqueous phases are separated, the aqueous phase is extracted with an organic solvent, preferably toluene, and the combined organic phases are washed, preferably with a saturated aqueous NaCl solution, dried, preferably over magnesium sulfate, and filtered.
  • the resulting solution of the compound of formula (I) can be directly used in step C) of the process according to the invention. It is also possible to isolate the compound of formula (I), preferably by evaporation of the organic solvent, preferably under reduced pressure.
  • the process according to the invention yields the compounds of formula (I) in high purity.
  • the compounds of formula (I) may be further purified by known techniques, for example distillation or chromatography.
  • Step C) is carried out in the presence of a base.
  • a base preferably include alkali metal or alkaline earth metal acetates, amides, carbonates, hydrogencarbonates, hydrides, hydroxides or alkoxides, for example sodium acetate, potassium acetate or calcium acetate, lithium amide, sodium amide, potassium amide or calcium amide, sodium carbonate, potassium carbonate or calcium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate or calcium hydrogencarbonate, lithium hydride, sodium hydride, potassium hydride or calcium hydride, lithium hydroxide, sodium hydroxide, potassium hydroxide or calcium hydroxide, n-butyllithium, sec-butyllithium, tert-butyllithium, lithium diisopropylamide, lithium bis(trimethylsilyl)amide, sodium methoxide, ethoxide, n- or i-propoxide, n-, i-, s- or t-butoxide or -
  • the base is selected from Na 2 C0 3 , K 2 C0 3 , Cs 2 C0 3 , NaOH, NaOMe, KOMe, KOtBu, NaH and mixtures thereof, more preferably form NaOMe, KOMe, K2CO3, CS2CO3 and mixtures thereof.
  • the base is KOMe.
  • the phenolate nucleophile can be generated in-situ by use of the abovementioned bases or prepared from the phenol derivative of formula (VII) and the base and possibly isolated prior to the reaction.
  • the generated MeOH is usually distilled off together with all or a portion of any present solvent.
  • step C) is carried out in the presence of an aprotic solvent, preferably selected from tetrahydrofuran, methyltetrahydrofuran, in particular 2-methyltetrahydrofuran, diethylether, cyclopropyl methyl ether, tert-buiyl methyl ether, methyl isobutyl ketone, methyl ethyl ketone, toluene, dimethylformamide (DMF) and mixtures thereof. More preferably step C) is carried out in the presence of methyl isobutyl ketone, methyl ethyl ketone, toluene or mixtures thereof. Most preferably the reaction is carried out in the presence of toluene.
  • an aprotic solvent preferably selected from tetrahydrofuran, methyltetrahydrofuran, in particular 2-methyltetrahydrofuran, diethylether, cyclopropyl methyl ether, tert-buiyl
  • step C) is carried out in the presence of a catalyst, preferably l,4-diazabicyclo[2.2.2]-octane (DABCO).
  • a catalyst preferably l,4-diazabicyclo[2.2.2]-octane (DABCO).
  • DABCO l,4-diazabicyclo[2.2.2]-octane
  • the catalyst is present in an amount of from 1 to 20 mol%, based on the amount of compound of formula (I).
  • the reagents used in step C) are mixed at room temperature (23°C). After mixing the reagents, preferably the temperature is increased. Preferably, step C) is carried out at an elevated temperature from 30°C to 150°C, preferably 50°C to 100°C.
  • the reaction mixture resulting from step C) can be worked-up by procedures generally known in the art.
  • the reaction mixture is quenched by addition of water and/or saturated aqueous ammonium chloride solution, the resulting organic and aqueous phases are separated, the aqueous phase is extracted with an organic solvent, preferably toluene, and the combined organic phases are washed, preferably with a saturated aqueous NaCl solution, dried, preferably over magnesium sulfate, and filtered.
  • the resulting solution of the compound of formula (VIII) or the crude product obtained by evaporation of the organic solvent can be directly used in step D) of the process according to the invention.
  • the compounds of formula (VIII) may be further purified by known techniques, for example recrystallization or chromatography.
  • step D) compounds of formula (VIII) are converted into epoxides of formula (IX) by reaction with a trimethylsulfoxonium halide, a trimethylsulfonium halide, trimethylsulfoxonium methylsulfate or trimethylsulfonium methylsulfate, preferably trimethylsulfoxonium chloride, trimethylsulfonium chloride, trimethylsulfoxonium methylsulfate or trimethylsulfonium methylsulfate.
  • trimethylsulfoxonium halide, trimethylsulfonium halide, trimethylsulfoxonium methylsulfate or trimethylsulfonium methylsulfate separately before using it in step D).
  • said reagents in situ e.g. trimethylsulfonium methylsulfate from a mixture of dimethylsulfide and dimethylsulfate, preferably in the presence of a base such as sodium hydroxide or potassium hydroxide.
  • the trimethylsulfoxonium halide, trimethylsulfonium halide, trimethylsulfoxonium methylsulfate or trimethylsulfonium methylsulfate is preferably used in an amount of 1.1 to 2.5, in particular 1.2 to 2, more preferred 1.3 to 1.6 mole equivalents per 1 mole of compound of formula (VIII).
  • trimethylsulfonium methylsulfate is used.
  • an aqueous solution of trimethylsulfonium methylsulfate is used, preferably an aqueous solution containing 38 to 40 wt%, preferably 38 to 39.5 wt%, more preferred 38 to 39.0 wt% of trimethylsulfonium kation.
  • step D) is carried out at a temperature of -30°C to 50°C, preferably -10°C to 40°C, particularly preferred 20°C to 40°C.
  • Step D) is preferably conducted in the presence of water, dimethylsulfide or a mixture thereof. It is preferably carried out in the presence of a base.
  • the base is selected from Na 2 CC>3, K 2 CO3, Cs 2 C0 3 , NaOH, KOH, KOtBu, NaH and mixtures thereof, more preferably the base is KOH.
  • the reaction mixture resulting from step D) can be worked-up by procedures generally known in the art.
  • the reaction mixture is quenched by addition of water.
  • Resulting organic and aqueous phases are separated, the aqueous phase is extracted with an organic solvent, preferably tert-buiyl methyl ether.
  • the resulting solution of the compound of formula (IX) or the crude product obtained by evaporation of the organic solvent and other volatile components can be directly used in step E) of the process according to the invention.
  • the compounds of formula (IX) may be further purified by known techniques, for example recrystallization or chromatography.
  • Step E) is carried out in the presence of a base.
  • alkali metal or alkaline earth metal acetates, amides, carbonates, hydrogencarbonates, hydrides, hydroxides or alkoxides for example sodium acetate, potassium acetate or calcium acetate, lithium amide, sodium amide, potassium amide or - - calcium amide, sodium carbonate, potassium carbonate or calcium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate or calcium hydrogencarbonate, lithium hydride, sodium hydride, potassium hydride or calcium hydride, lithium hydroxide, sodium hydroxide, potassium hydroxide or calcium hydroxide, n-butyllithium, sec-butyllithium, tert-butyllithium, lithium diisopropylamide, lithium bis(trimethylsilyl)amide, sodium methoxide, ethoxide, n- or i-propoxide, n-, i-, s- or t-butoxide or potassium methoxide, ethoxide, n- or i
  • the base is selected from Na 2 C0 3 , K 2 C0 3 , Cs 2 C0 3 , NaOH, KOH, KOtBu, NaH and mixtures thereof, more preferably form KOH, K2CO3, CS2CO3 and mixtures thereof.
  • a sodium or potassium salt of lH-l,2,4-triazole is used as base.
  • Said sodium or potassium salt can be prepared by reacting lH-l,2,4-triazole and a sodium or potassium base, preferably selected from NaOH, NaH and Na-alcoholates or KOH and K-alcoholates, respectively.
  • step E) is carried out in the presence of an organic solvent, preferably selected from tetrahydrofuran, methyltetrahydrofuran, in particular 2-methyltetrahydrofuran, diethylether, cyclopropyl methyl ether, tert-buiyl methyl ether, toluene, n-butanol, n-propanol, isopropanol, ethanol, methanol, N- methylpyridione (NMP), dimethylformamide (DMF) and mixtures thereof, more preferably in the presence of n-butanol.
  • an organic solvent preferably selected from tetrahydrofuran, methyltetrahydrofuran, in particular 2-methyltetrahydrofuran, diethylether, cyclopropyl methyl ether, tert-buiyl methyl ether, toluene, n-butanol, n-propanol, isopropanol,
  • step E) is carried out at a temperature of 20°C to 150°C, preferably 120°C to 150°C, particularly preferred 120°C to 140°C.
  • the reaction mixture resulting from step E) can be worked-up by procedures generally known in the art.
  • all volatile compounds are evaporated under reduced pressure and the residue is re-dissolved in a suitable organic solvent like ethyl acetate.
  • Water is added and the pH (room temperature) is adjusted to about 6 by introduction of a strong acid like concentrated aqueous hydrochloric acid.
  • the aqueous phase is extracted with a suitable organic solvent like ethyl acetate, and the combined organic phases are dried, preferably over magnesium sulfate.
  • the organic solvent is removed and the resulting crude product further purified by known techniques, for example recrystallization or chromatography.
  • the reaction time of each of the steps of the process according to the invention varies depending on the scale of the reaction and the reaction temperature, but is generally between a few, e.g. 5, minutes and 48 hours.
  • process steps according to the invention are generally performed under standard pressure (1 atm). However, it is also possible to work under elevated or reduced pressure.
  • the invention is particularly useful to produce compounds of formula (I)
  • R represents CF3
  • R 1 represents Ci-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl
  • X represents fluorine or chlorine.
  • R represents CF3
  • R 1 represents methyl
  • X represents chlorine
  • a particularly useful educt is the compound of formula (Ila)
  • the Grignard solution of the first vessel was added under cooling to the second vessel containing the acetic anhydride while keeping the inner temperature at -5 to 0 °C. After stirring for 1 hour (h) at that temperature the reaction was quenched with 150 mL of a saturated ammonium chloride solution in water. The phases were separated and the aqueous phase was extracted twice with toluene. The combined organic phases were washed with a saturated NaCl solution, dried over magnesium sulfate, filtered and evaporated under reduced pressure, giving 80,7 g of l-[6-chloro-2-(trifluoromethyl)-3-pyridyl]ethanone in 82% purity (87.9% yield).
  • Comparative example 1 According to process B known from WO 2017/029179 Al under a blanket of argon 20 g of 3-bromo-6- chloro-2-(trifluoromethyl)pyridine (75.5 mmol) were added to 50 mL of toluene. The mixture was cooled below -5 °C and iPrMgCl (1.7M solution in THF, 75.5 mmol, 1 equiv) was added dropwise over 60 minutes while keeping the inner temperature below -5 °C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne un procédé de préparation d'un composé de formule (I) dans laquelle R représente hydrogène, halogénoalkyle en C1-C2, halogénoalcoxy en C1-C2, alkylcarbonyle en C1-C2, fluor ou chlore, R1 représente alkyle en C1-C6, alcényle en C2-C6, alcynyle en C2-C6, cycloalkyle en C3-C8, C3-C8-cycloalkyl-C1-C4-alkyle, phényle, phényl-C1-C4-alkyle, phényl-C2-C4-alcényle ou phényl-C2-C4-alcynyle et X représente du fluor ou du chlore ; en faisant réagir un composé de formule (II) dans une première étape A) avec un composé de formule R'MgY (III), dans laquelle R représente alkyle en C1-C6 ou cycloalkyle en C3-C8 ; et Y représente chlore ou brome ; et une étape B) avec un anhydride de formule (IV) et éventuellement faire réagir le composé de formule (I) avec un dérivé de triazole de formule (VI).
PCT/EP2018/073963 2017-09-11 2018-09-06 Procédé de préparation de 1-[6-halogéno-3-pyridyl]cétones Ceased WO2019048526A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17190359 2017-09-11
EP17190359.4 2017-09-11

Publications (1)

Publication Number Publication Date
WO2019048526A1 true WO2019048526A1 (fr) 2019-03-14

Family

ID=59846483

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/073963 Ceased WO2019048526A1 (fr) 2017-09-11 2018-09-06 Procédé de préparation de 1-[6-halogéno-3-pyridyl]cétones

Country Status (2)

Country Link
TW (1) TW201920106A (fr)
WO (1) WO2019048526A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202807A1 (fr) * 2015-06-17 2016-12-22 BASF Agro B.V. Procédé pour la préparation de phénylcétones substituées
WO2017029179A1 (fr) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Dérivés de triazole, leurs intermédiaires et leur utilisation comme fongicides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202807A1 (fr) * 2015-06-17 2016-12-22 BASF Agro B.V. Procédé pour la préparation de phénylcétones substituées
WO2017029179A1 (fr) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Dérivés de triazole, leurs intermédiaires et leur utilisation comme fongicides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MILTON ORCHIN, JOURNAL OF CHEMICAL EDUCATION, vol. 66, no. 7, 1999, pages 586 - 588

Also Published As

Publication number Publication date
TW201920106A (zh) 2019-06-01

Similar Documents

Publication Publication Date Title
JP6676038B2 (ja) ヘキサフルオロプロペンから出発する5−フルオロ−1h−ピラゾール類の調製のための方法
TWI694066B (zh) 始於六氟丙烯之製備5-氟-1h-吡唑的方法
CN105934428B (zh) 制备5-氟-1h-吡唑的方法
WO1995017408A1 (fr) Synthese de diarylmethanes
WO2019048526A1 (fr) Procédé de préparation de 1-[6-halogéno-3-pyridyl]cétones
WO2020025574A1 (fr) Procédé de préparation de 6-(haloalkyl)-2-halo-5-acylpyridines et d'intermédiaires pour ce procédé
KR100973616B1 (ko) 1,2,4-트리아졸릴메틸-옥시란의 제조 방법
KR20070115896A (ko) (z)-1-페닐-1-(n,n-디에틸아미노카르보닐)-2-프탈이미도메틸시클로프로판의 제조 방법
TW202012372A (zh) 製備2-(氟烷基)菸鹼酸的方法
US6992221B2 (en) Process to prepare aryltriazolinones and novel intermediates thereto
WO2020120284A1 (fr) Préparation de 6-halo-2-(haloalkyl)-3-acylpyridines et intermédiaires correspondants
WO2019012161A1 (fr) Procédé pour la préparation de (1h-1,2,4-triazol-1-yl)alcools substitués
JP2019504088A (ja) 置換4−アミノインダン誘導体を製造する方法
EP3738959A1 (fr) Préparation de 6-phénoxy-2-(haloalkyl)-3-acylpyridines et de leurs intermédiaires
KR20170070037A (ko) 할로-치환된 트리플루오로아세토페논의 제조 방법
JP6998957B2 (ja) 3-置換2-ビニルフェニルスルホネート類を製造する方法
WO2007090464A1 (fr) Procede de preparation de la letrozole
KR20010024785A (ko) N-(3-아미노-4-플루오로페닐)-설폰아미드,n-(3-아미노-4-플루오로페닐)-카복실산 아미드 및n-(3-아미노-4-플루오로페닐)-카바메이트의 제조방법
EP1440968A1 (fr) Procédé de preparation d'aryltriazolinones et de leurs nouveaux intermediaires
JPH05230010A (ja) パラクロロフェニルカルバミン酸エステルの製造方法
JPH0441471A (ja) 2―ニトロ―5―(置換フエノキシ)ベンゾヒドロキシム酸誘導体の製造法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18762106

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18762106

Country of ref document: EP

Kind code of ref document: A1